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Requirements for CD4+ T cell memory differentiation
were analyzed with adoptively transferred SMARTA
T cell receptor (TCR) transgenic cells specific for a
lymphocytic choriomeningitis virus (LCMV) epitope.
LCMV-induced effector and memory differentiation
of SMARTA cells mimicked the endogenous CD4+ T
cell response. In contrast, infection with a recombi-
nant Listeria expressing the LCMV epitope, although
resulting initially in massive SMARTA expansion, led
to loss of effector function and rapid cell death char-
acterized by high expression of the apoptosis regu-
lator Bim. Defective memory differentiation was seen
after stimulation of naive but not memory SMARTA
cells, was independent of precursor frequency, and
correlated with a lower TCR avidity compared to en-
dogenous responders. In addition, long-lived endog-
enous CD4+ memory T cells skewed to a higher func-
tional avidity over time. These results support
a model in which CD4+ T cell memory differentiation
and longevity depend on the strength of the TCR
signal during the primary response.
INTRODUCTION
After acute infection, antigen-specific T cells expand as much as
50,000-fold, acquire effector function and mediate clearance of
the pathogen. After resolution of the infection, 90%–95% of an-
tigen-specific T cells die, leaving behind a long-lived population
of memory T cells that provide protection upon reinfection (Wil-
liams and Bevan, 2007; Kaech and Wherry, 2007). Memory T
cells possess several properties crucial for their function, includ-
ing higher frequencies than naive precursors, the ability to rap-
idly reactivate upon antigen stimulation, wide tissue distribution,
and the ability to survive and self-renew for long periods in the
absence of cognate antigen.
In recent years, it has become clear that numerous signals dur-
ing the primary phase of the immune response can impact the
differentiation of functional memory. CD4+ T cells are thought
to deliver signals important for the survival and protective func-
tion of ensuing CD8+ memory T cells, even though the primary
CD8+ T cell response to a pathogen is often unaffected by their
absence (Janssen et al., 2003; Shedlock and Shen, 2003; Sunand Bevan, 2003). Interleukin-2 (IL-2) signals have also been
shown to play an important role in the differentiation of memory
cells capable of secondary expansion (Williams et al., 2006;
Bachmann et al., 2007). Expression of IL-7Ra on T cells at the
peak of the effector response to acute infection correlates with
the ability to survive the contraction phase and progress tomem-
ory (Kaech et al., 2003), although IL-7 signals themselves do not
appear to be sufficient for this process (Hand et al., 2007;
Klonowski et al., 2006; Sun et al., 2006). These findings have
illustrated the need to accurately define the signals during the
primary response that promote the differentiation of memory
cells with their distinctive properties.
The role of T cell receptor (TCR) signals in the development of
memory T cells is not fully understood. In one proposed sce-
nario, repeated encounters with antigen drive the continued
expansion and differentiation of T cell populations, with higher
degrees of TCR stimulation driving the differentiation to memory
(Gett et al., 2003; Lanzavecchia and Sallusto, 2002). However,
another model proposes that once the initial encounter with an-
tigen has reached a certain activation threshold, responding T
cells expand and differentiate independently of further TCR sig-
nals (Prlic et al., 2007). In support of this, CD8+ T cells stimulated
with antigen for a short period in vivo or in vitro can undergo
expansion, gain effector function, and differentiate to memory
(Kaech and Ahmed, 2001; Mercado et al., 2000; van Stipdonk
et al., 2003). In vivo antigenic recognition of as little as 6–12 hr,
in the context of an inflammatory response, is sufficient to drive
effector andmemory CD8+ T cell development (Prlic et al., 2006).
Inflammatory signals themselves during viral or bacterial infec-
tions also preferentially promote the development of end-stage
effectors over memory cells (Joshi et al., 2007; Pearce and
Shen, 2007).
Evidence indicates that the requirements for effector and
memory differentiation differ for CD4+ and CD8+ T cells. A short-
ened period of stimulation in vivo does not impact the develop-
ment of the CD8+ T cell effector response but results in a greatly
decreased CD4+ T cell response (Obst et al., 2005; Williams and
Bevan, 2004), implying a role for continued antigen stimulation in
the development of CD4+ T cell responses. Furthermore, in some
instances CD4+ memory T cells have shown a gradual decline
over time after acute infection in mice, in contrast to the stability
of CD8+ memory T cell populations (Homann et al., 2001). This
seems to conflict with observations of CD4+ memory T cells in
humans, which persist for up to 75 years with a half-life similar
to that seen for CD8+ memory T cells (Hammarlund et al.,
2003). Understanding the differentiation and maintenance ofImmunity 28, 533–545, April 2008 ª2008 Elsevier Inc. 533
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Selection of CD4 Memory RepertoireCD4+ memory T cells after infection remains an important focus
of study, particularly because it relates to the development
of vaccine strategies for the targeted stimulation of CD4+ T cell
responses.
We employed a model of adoptive transfer of TCR transgenic
T cells to study CD4+ T cell memory differentiation in vivo.
SMARTA mice express a TCR transgene with specificity for the
immunodominant I-Ab-restricted GP61–80 epitope of lymphocytic
choriomeningitis virus (LCMV). Small numbers (103–104) of naive
CD4+ SMARTA T cells (Thy1.1+) transferred into C57BL/6 (B6)
hosts expanded dramatically after LCMV infection. They also dif-
ferentiated into cytokine-producing effector cells and long-lived
memory cells similarly to endogenous CD4+ T cell responders
specific for the same epitope. After infection with a recombinant
Listeria monocytogenes secreting GP61–80 (Lm-gp61), naive
SMARTA cells also expanded dramatically (10,000- to 20,000-
fold). After resolution of the Lm-gp61 infection, however,
SMARTA cells rapidly lost cytokine-producing function and
failed to differentiate into memory, despite the development of
readily detectable memory populations by endogenous re-
sponders to the same epitope in the same animal. As early as
day 5 p.i., SMARTA cells were doomed to die and could not be
rescued through further stimulation. Only naive SMARTA cells
failed to formmemory. Memory SMARTA cells initially generated
during LCMV infection and then rechallenged with Lm-gp61
readily expanded, differentiated, and formed secondary memory
populations. Microarray analysis revealed that the failure to dif-
ferentiate into memory coincided with increased Bim and de-
creased Bcl-2 expression at the peak of the response. To assess
the role of antigen availability in driving CD4+ T cell differentiation
in these two model systems, we measured the functional avidity
of endogenous and SMARTA CD4 responders after infection, as
defined by the dose of antigen required to elicit a functional re-
sponse (i.e., IFNg production). Failure of the SMARTA cells to dif-
ferentiate into memory correlated with decreased functional
avidity as compared to the endogenous Lm-gp61 responders
in the same host, suggesting that the limited antigen available
during Lm-gp61 infection was insufficient to promote SMARTA
memory differentiation. In addition, long-lived CD4+ memory T
cell populations (>6 months) were characterized by the emer-
gence of cells with higher functional avidity. These data support
amodel in which the differentiation of effector andmemory CD4+
T cells, as well as the longevity of the ensuing CD4+ memory T
cell population, is driven by the strength of antigen stimulation
during the primary response.
RESULTS
SMARTA Cells Mimic the Endogenous CD4+ T Cell
Response to LCMV
In order to track in vivo CD4+ T cell responses to acute infection,
we employed an adoptive-transfer system utilizing SMARTA
CD4+ TCR transgenic T cells. We transferred 1 3 104 congeni-
cally marked (Thy1.1+) CD44lo SMARTA cells specific for the
I-Ab-restrictedGP61–80 epitope of LCMV into B6 hosts 1 day prior
to LCMV infection. SMARTA cells expanded dramatically during
the first week of infection in the spleen (Figure 1A), lymph nodes,
and peripheral tissues such as the lung and liver (data not
shown). By day 30 p.i., the majority of the SMARTA cells died,534 Immunity 28, 533–545, April 2008 ª2008 Elsevier Inc.leaving behind a long-lived memory population. The memory
maintenance phase was characterized by a gradual decline in
SMARTA numbers, although substantial numbers of SMARTA
cells were readily detectable in the spleen up to 385 days p.i.
The rate of decline in memory cell numbers also decreased
over time (Figure 1A). The overall kinetics of the SMARTA re-
sponse to LCMV infection largely mirrored the polyclonal endog-
enous CD4+ T cell response to the same GP61–80 epitope (data
not shown).
In addition to displaying similar kinetics, the functional devel-
opment of the SMARTA cells was similar to that of the endoge-
nous CD4+ T cell responders in the same animal. At both the
peak of the effector response (day 8 p.i.) and at memory time
points, the bulk of the SMARTA cells maintained the ability to
produce Interferon-g (IFNg), IL-2, and tumor necrosis factor-
a (TNFa), with a cytokine production profile similar to that of
the endogenous CD4+ T cell responders (Figure 1B). Combined
with the kinetics of the SMARTA response, these results led us to
conclude that SMARTA cells could be used as an effective sur-
rogate for endogenous CD4+ T cell responses during LCMV in-
fection (Whitmire et al., 2006).
SMARTA Cells Expand and Differentiate after Lm-gp61
Infection but Fail to Form Memory
In order to study SMARTA differentiation in another model sys-
tem, we infected host mice with recombinant Listeria monocyto-
genes expressing the I-Ab-restricted GP61–80 epitope of LCMV
under the control of the LLO promoter (Lm-gp61). By day
8 p.i., SMARTA cells had expanded dramatically, although they
were present at lower frequencies and total numbers in the
spleen than SMARTA cells 8 days after LCMV infection. By day
60, however, SMARTA cells had completely disappeared from
the spleens of Lm-gp61-infected animals (Figures 2A and 2D).
In contrast, after either infection, endogenous CD4+ T cell re-
sponders in the same animal specific for the same epitope
were readily detectable at the peak of the response (day 8 p.i.)
and at memory time points (day 60) (Figures 2B and 2D). Similar
results were found in the liver (data not shown). A closer look at
the day 8 response to Lm-gp61 revealed that although the
SMARTA cells expanded several thousand fold during the first
week of infection, they failed to differentiate properly in compar-
ison to the endogenous responders, as measured by their ability
to produce cytokines. Whereas the great majority of IFNg-pro-
ducing endogenous CD4+ T cell responders also produced
TNFa and IL-2, only a small proportion of SMARTA cells at this
time point retained this ability (Figure 2C). Furthermore, produc-
tion of all three cytokines by SMARTA cells in response to pep-
tide stimulation was much lower, as measured by mean fluores-
cence intensity of intracellular staining.
We analyzed the kinetics and cytokine profile of the SMARTA
response in greater detail during the first 2 weeks after Lm-gp61
infection (Figure 3A). SMARTA cells were readily detectable at
5 days p.i. Furthermore, at this early stage, their ability to pro-
duce both IFNg and TNFa mirrored that of the endogenous re-
sponders. Although they continued to expand until day 7 p.i.,
most of the SMARTA cells lost the ability to produce TNFa be-
tween day 5 and day 7, as compared to the endogenous CD4+
T cell responders that retained the ability to secrete high
amounts of both cytokines. We observed a similar decline in
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Selection of CD4 Memory RepertoireFigure 1. Adoptively Transferred SMARTA Cells Mimic the Endogenous CD4+ T Cell Response to LCMV
(A) Thy1.1+CD44lo SMARTA cells (1 3 104) were transferred into B6 hosts (Thy1.2+). Mice were infected with LCMV 1 day later, and the subsequent expansion,
contraction, and memory maintenance of SMARTA cells in the spleen were calculated on the basis of expression of Thy1.1. Error bars display the standard error
of the mean (SEM) (n = 3–4 per time point), and results are representative of four different experiments.
(B) Splenocytes harvested at day 8 or day 300 p.i. were restimulated with GP61–80 peptide for 4 hr in the presence of Brefeldin A. Cells were then stained for in-
tracellular expression of IFNg, TNFa, and IL-2.We gated onCD4+ Thy1.1+ SMARTA responders and CD4+Thy1.1 endogenous responders from the same animal
and assessed their ability tomake each cytokine at each time point. Flow plots are representative of effector andmemory time points over the course of four time-
course experiments.the ability of SMARTA cells to produce IL-2 between days 5 and
7 (data not shown). Whereas the number of endogenous re-
sponders declined slowly through the contraction phase until
day 15 p.i., SMARTA numbers dropped precipitously. At day
12 they represented only 0.1% of the CD4 population, and by
day 15 they were undetectable (Figure 3A). Furthermore, rechal-
lenge with LCMV at day 5 p.i. with Lm-gp61 failed to rescue the
SMARTA cells, for under these conditions SMARTA cells were
still undetectable by day 15 p.i. (Figure S1 available online).
These data indicated that not only were SMARTA cells progres-
sively losing functional capacity by days 5–7 p.i., but they were
also irreversibly committed to undergoing programmed cell
death.
We asked whether memory SMARTA cells generated by
LCMV infection could form secondary memory after rechallenge
with Lm-gp61. Infection with LCMV gave rise to a readily detect-
able SMARTA memory population 180 days later, with frequen-
cies ranging from 0.2% to 1.0% of CD4+ T cells in the spleen,
lymph nodes, and liver (data not shown). After rechallenge with
Lm-gp61 at this time point, SMARTA memory cells expanded
dramatically, differentiated normally as measured by IFNg and
TNFa production, and differentiated to readily detectable sec-
ondarymemory by day 42 after rechallenge (Figure 3B). As a con-
trol for this experiment, mice receiving naive SMARTA cells and
given a primary challengewith Lm-gp61 failed to develop detect-able SMARTA memory cells at day 42 p.i. (data not shown).
Therefore, unlike naive SMARTA cells, memory SMARTA cells
do have the ability to differentiate to secondary memory after
Lm-gp61 infection.
Failed SMARTA Memory Differentiation Is Independent
of Precursor Frequency
We next considered the possibility that the inability of SMARTA
to differentiate into memory after Lm-gp61 infection could de-
pend on the precursor frequency of responding cells. Clonal
competition has been shown to play an important role in the se-
lection, differentiation, and survival of CD4+ T cell responders
in vivo (Foulds and Shen, 2006). We hypothesized that after
Lm-gp61 infection, competition for limited access to antigen or
to differentiation and growth factors due to abnormally high pre-
cursor frequencies might prevent normal memory differentiation
of the SMARTA cells. By assuming a ‘‘take’’ of 10% of adop-
tively transferred cells, as confirmed with high-frequency trans-
fers (data not shown), we estimated that our previous transfers of
13 104 SMARTA cells resulted in a precursor frequency of13
103, or roughly 5–20-fold higher than the estimated endogenous
precursor frequency for this epitope (Whitmire et al., 2006).
To test the possibility that clonal competition prevented
SMARTA memory differentiation, we transferred 1 3 103, 1 3
104, or 1 3 105 SMARTA cells into naive B6 mice that wereImmunity 28, 533–545, April 2008 ª2008 Elsevier Inc. 535
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Selection of CD4 Memory RepertoireFigure 2. SMARTA Cells Expand but Fail to
Gain Full Effector Function and Form Mem-
ory after Lm-gp61 Infection
(A) Thy1.1+CD44lo SMARTA cells (1 3 104) were
transferred into B6 hosts (Thy1.2+). Mice were in-
fected with Lm-gp61 or LCMV 1 day later, and
the expansion, contraction, and memory mainte-
nance of SMARTA cells in the spleen were as-
sessed. Representative flow plots display the fre-
quency of Thy1.1+CD4+ SMARTA cells in the
spleen at day 8 and day 60 p.i. for each infection.
(B) Representative flow plots display the fre-
quency of IFNg-producing endogenous CD4+ re-
sponders (CD4+Thy1.1) in the spleen after pep-
tide restimulation in the presence of Brefeldin A.
(C) Representative flow plots compare the ability
of SMARTA cells (CD4+Thy1.1+) and endogenous
CD4+ responders (CD4+Thy1.1) in the spleen to
make IFNg, TNFa, and IL-2 after peptide restimu-
lation at day 8 p.i. Flow plots are representative of
six separate experiments.
(D) The number of SMARTA (Thy1.1+) and endog-
enous (IFNg-producing) responders in the spleen
are shown for day 8 and day 60. Error bars repre-
sent the SEM (n = 3 per group).infected with Lm-gp61 1 day later. At day 7 p.i., SMARTA cells
were readily detectable in the spleens of all groups, with the
highest frequencies and largest numbers harvested from the
group that received 1 3 104 SMARTA cells (Figures 4A and
4B). However, the greatest expansion was observed in the group
that received 1 3 103 SMARTA cells. Assuming a 10% ‘‘take’’
and estimating an actual precursor frequency of 100 SMARTA536 Immunity 28, 533–545, April 2008 ª2008 Elsevier Inc.cells in this group (which is similar to that of endogenous precur-
sor frequencies), we calculated a 12,000- to 16,000-fold expan-
sion by SMARTA cells during the first 7 days after Lm-gp61 infec-
tion (Figure 4C). Remarkably, however, such massive expansion
was not accompanied by enhanced differentiation, as measured
by their ability to make IFNg, TNFa, and IL-2 (data not shown),
nor did it confer the properties necessary formemory generation,Figure 3. After Lm-gp61 Infection, Naive
SMARTA Cells Lose Function and Disap-
pear whereas Memory SMARTA Differenti-
ate Normally
(A) Thy1.1+CD44lo SMARTA cells (1 3 104) were
transferred into B6 hosts (Thy1.2+). Mice were in-
fected with Lm-gp61 1 day later, and SMARTA
cells were subsequently tracked in the spleen at
several time points p.i. on the basis of Thy1.1 ex-
pression (left column). Cytokine production by
SMARTA (middle column) and endogenous (right
column) CD4+ T cell responders from the same an-
imal was assessed at the indicated points. Flow
plots are representative of three mice per time
point in this experiment, and similar results were
found in three separate experiments.
(B) Thy1.1+CD44lo SMARTA cells (1 3 104) were
transferred into B6 hosts (Thy1.2+). Mice were in-
fected with LCMV 1 day later and then rechal-
lenged with Lm-gp61 180 days after the primary
infection. Representative flow plots display the
frequency of SMARTA cells in the spleen at 7
and 42 days after rechallenge (top row). The bot-
tom row displays the ability of SMARTA cells at
each time point to produce IFNg and TNFa in re-
sponse to ex vivo peptide restimulation. Plots are
representative of 3–4 mice per group.
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Selection of CD4 Memory Repertoireas evidenced by our observation that SMARTA cells were unde-
tectable in all groups by day 50 p.i. regardless of precursor fre-
quency (Figure 4A). Therefore, we concluded that the signals
required for CD4+ T cell memory differentiation can be disasso-
ciated from those required for robust clonal expansion during the
primary phase of the response. Furthermore, clonal competition
could not be invoked to explain the inability of SMARTA cells to
form memory after Lm-gp61 infection.
SMARTA Gene-Expression Profile
In order to explore the mechanism leading to the death of
SMARTA responders after Lm-gp61 infection, we analyzed the
gene-expression profiles of SMARTA cells 7 days after infection
with either LCMV or Lm-gp61 via gene-expression microarrays
(Tables 1 and 2). This analysis demonstrated stark differences
in the gene-expression profile of SMARTA cells responding to
each type of infection. SMARTA cells after Lm-gp61 infection
demonstrated increased expression of 65 genes of known func-
tion (as defined by an averageR 3-fold increase in expression in
two separate experiments). Of these, 45 encoded gene products
with known suppressive or regulatory activities as transcriptional
repressors (e.g., TSC-22, Tob2), inhibitors of cell cycle or cellular
activation (e.g., Rap2A, Unc5cl, PP2A, Ptger4), or proapoptotic
factors (e.g., Bim, Nor-1, FoxO3a, FasL). In contrast, after
LCMV infection, over 300 genes demonstrated increased ex-
pression, including genes that encode antiapoptotic factors
(e.g., Bcl-2, Hsp110, SODD), growth and activation factors
Figure 4. SMARTA Cells Fail to Differentiate into Memory after
Lm-gp61 Infection Regardless of Naive-Precursor Frequency
(A) Thy1.1+CD44lo SMARTA cells (1 3 103, 1 3 104, or 1 3 105) were trans-
ferred into B6 hosts (Thy1.2+) that were infected with Lm-gp61 1 day later.
Representative flow plots display the frequency of Thy1.1+ SMARTA cells
among total CD4+ T cells at days 7 and 50 p.i. for each cell dose.
(B) Bar graph displays the number of SMARTA cells harvested at day 7 p.i. after
transfer of the indicated number of naive SMARTA cells.
(C) Bar graph displays the n-fold expansion of SMARTA cells at each cell dose
during the first week p.i. Starting numbers were calculated on the basis of
a 10% ‘‘take’’ of transferred cells. Error bars represent the SEM (n = 3 per
group).(e.g., b-catenin, TCF-1, CD27, CD122), trafficking receptors
(e.g., CXCR5, CD43), and gene products involved in metabolic
pathways, cell cycling, chromatin remodeling, transcription
and cellular activation, and regulation of TCR signals and cellular
growth. These data indicate that SMARTA cells at day 7 after
Lm-gp61 infection are undergoing apoptosis and are refractory
to activation signals. Of particular interest is the discoordinated
expression of the genes encoding Bim and Bcl-2, two molecules
that have been shown to have opposing effects on T cell survival
during various phases of the immune response (Marrack and
Kappler, 2004). The microarray results for Bcl-2, b-catenin,
TCF-1, Nor-1, and Bim have been further confirmed by real-
time PCR (Figure S2). Intracellular staining also revealed
decreased Bcl-2 protein expression after Lm-gp61 infection
(Figure S2).
Together, these data strongly suggest that stimulation of the
SMARTAcells during Lm-gp61 infection induces rapidexpansion
but defective differentiation and eventual programmed cell
death. Given the rapid disappearance of the SMARTA cells,
one concern was that they are rejected during Listeria infection,
whether as a result of the expression of the Thy1.1 congenic
marker or minor histocompatibility differences not eliminated
during backcrossing. Several lines of evidence indicate that this
is not the case. First, the loss of function as reflected by cytokine
production is indicative of failed differentiation, not rejection.
Second, the gene-expression profile is also indicative of failed
differentiation and programmed cell death, with increased ex-
pression of key apoptotic factors. Third, memory SMARTA chal-
lengedwith Lm-gp61 readily form secondary memory, indicating
that the failure of naive SMARTA to form primary memory after
stimulation is probably due to differences in activation threshold,
not rejection. To definitively address the issue of rejection, we
transferred day 8 SMARTA from either Lm-gp61- or LCMV-
infected hosts into secondary hosts that were also day 8 p.i.
with either Lm-gp61 or LCMV and that had also received an initial
SMARTA transfer prior to infection (to ensure that the mice were
‘‘primed’’). In order to distinguish the secondary SMARTA trans-
fer from the initial SMARTA transfer in these hosts, we labeled the
transferred SMARTA cells with CFSE. Seven days later (15 days
p.i.), the survival of SMARTA cells in the spleen was assessed.
Although some CFSE dilution was observed, primary and sec-
ondary SMARTA transfers were distinguishable. As expected,
SMARTA cells generated in a Lm-gp61-infected host and in-
jected into a Lm-gp61-infected host largely disappeared,
whereas SMARTA cells generated in a LCMV-infected host and
transferred into a LCMV-infected host were readily detectable.
Conversely, SMARTA cells generated in a Lm-gp61-infected
host and injected into a LCMV-infected host disappeared within
7 days, whereas SMARTA cells generated in a LCMV-infected
host and transferred into a Lm-gp61-infected host demonstrated
no impairment in survival (FigureS3).Wewere therefore unable to
detect any mechanism for rejecting SMARTA cells in Lm-gp61-
infected animals and definitively ruled out this possible explana-
tion for their disappearance.
Failed SMARTA Memory Differentiation Correlates
with Low Functional Avidity
Previous studies have indicated that CD4+ T cells undergo avid-
ity maturation throughout the primary response to pathogen asImmunity 28, 533–545, April 2008 ª2008 Elsevier Inc. 537
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FoxO3a 5 tolerance,
apoptosis
(Lin et al., 2004;
Stahl et al., 2002)
FasL 7 apoptosis, AICD (Green et al., 2003)
Unc5cl 4 apoptosis (death
domain), inhibits
NF-kB
(Zhang et al., 2004)
Bach-2 9 transcriptional
repressor, apoptosis














(Chen et al., 2006)
Tis7 3 transcriptional
repressor
(Vietor and Huber, 2007)
Tob2 3 transcriptional
repressor
of T cell activation




(Scott and Plon, 2005)
Rap2A 7 prevents Akt
activation




(Parry et al., 2005)





(Metcalfe et al., 2005)
SLAP 3 TCR degradation (Myers et al., 2005)
Pdcd4 3 programmed cell
death, AP-1 inhibitor
(Bitomsky et al., 2004)
Ptger4 3 suppresses CD4
T cell activation
(Kabashima et al., 2002)
Cyclin D2 4 cell cycle
PI3K 3 TCR-induced T
cell activation
Genes whose upregulated expression is induced by Lm-gp61. Approxi-
mately 70% of upregulated mRNA with gene products of known function
encode genes with described or predicted involvement in suppression of
cell proliferation, activation, differentiation, or promotion of apoptosis
(45/65).538 Immunity 28, 533–545, April 2008 ª2008 Elsevier Inc.well as during subsequent rechallenges (Savage et al., 1999;
Whitmire et al., 2006). These results support the idea that
CD4+ T cell effector differentiation and the selection of respond-
ing repertoires is driven at least in part by the strength of anti-
genic stimulation. Furthermore, the observation that memory
SMARTA challenged with Lm-gp61 readily differentiated into
secondary memory suggested the possibility that their ability
to differentiate could be due to the lower activation threshold
of memory cells. Therefore, we hypothesized that the density
of antigen on the APC could also impact the selection of CD4+
T cell responders for differentiation intomemory. In this scenario,
a certain degree of TCR stimulation might be required for clonal
expansion, but further stimulation would be required for memory
differentiation. In our model system, high antigen density pro-
vided by LCMV infection might promote the expansion and
differentiation of CD4+ T cell responders over a wider range of
functional avidities, whereas lower antigen density provided by
Lm-gp61 infection might allow memory differentiation of only
high functional avidity responders. SMARTA cells, if they were
of low avidity, would be able to initially expand and differentiate
after Lm-gp61 infection but would lack sufficient TCR signals to
progress to memory.
We tested this hypothesis by measuring the functional avid-
ities of SMARTA and endogenous CD4+ T cell responders at
the peak of the primary response to either LCMV or Lm-gp61.
The functional avidity of the responding populations was mea-
sured by assessing their ability to produce IFNg ex vivo in
Table 2. Upregulated Gene Expression in SMARTA Responders 7





Bcl-2 8 antiapoptotic (Marrack and Kappler, 2004)
SODD 4 silencing of
death domains,
anti-apoptotic
(Jiang et al., 1999)
Hsp110 11 stress response,
survival
(Yamagishi et al., 2006)
b-catenin 9 T cell survival,
proliferation
(Qiang and Rudikoff, 2004)
TCF-1 8 T cell survival,
proliferation
(Qiang and Rudikoff, 2004)
CD27 5 T cell survival,
differentiation
(Hendriks et al., 2003)
CD122 3 T cell growth,
survival
(Waldmann, 2006)
CD43 9 T cell expansion,
migration
(Onami et al., 2002)
CXCR5 9 T cell trafficking to
germinal center
(Breitfeld et al., 2000;
Schaerli et al., 2000)
Genes whose upregulated expression is induced by LCMV. More than
300 genes of known function demonstrated upregulated expression
(data not shown) and can generally be segregated into the following
categories: stress response/DNA repair; metabolic pathways; cell-cycle
signaling pathways of cellular activation, proliferation, and survival;
chromatin structure; trafficking receptors (e.g., CXCR5); growth/survival
factor receptors (e.g., CD122); negative regulators of TCR-mediated sig-
naling; and transcription factors associated with cellular activation.
Immunity
Selection of CD4 Memory RepertoireFigure 5. SMARTA Responders Demonstrate Lower Functional Avidity, as Compared to Endogenous CD4+ T Cell Responders to Lm-gp61
in the Same Host
(A) B6 mice were infected with either LCMV or Lm-gp61. Eight days later, splenocytes were restimulated over a range of GP61–80 peptide concentrations and
stained for expression of IFNg and TNFa. Representative flow plots are gated on CD4+ T cells and show the frequency of cytokine producers after restimulation
at the indicate peptide concentrations.
(B) The graph displays the number of endogenous CD4+ T cells in the spleen capable of producing IFNg in response to decreasing concentrations of peptide.
(C) Thy1.1+CD44lo SMARTA cells (13 104) were transferred into B6 hosts (Thy1.2+), andmice were infectedwith LCMV1 day later. The graph displays the percent
maximal endogenous or SMARTACD4+ T cell response induced by ex vivo peptide restimulation, asmeasured by the frequency of IFNg-producing responders at
each peptide concentration divided by the frequency of IFNg-producing responders at the highest peptide concentration (1 3 105 M).
(D) Thy1.1+CD44lo SMARTA cells (1 3 104) were transferred into B6 hosts (Thy1.2+), and mice were infected with Lm-gp61 1 day later. The graph displays the
percent maximal endogenous or SMARTA CD4+ T cell response induced by ex vivo peptide restimulation, as measured by the frequency of IFNg-producing re-
sponders at each peptide concentration divided by the frequency of IFNg-producing responders at the highest peptide concentration (13 105M). The error bars
represent the SEM (n = 3 per group). Results are representative of four separate experiments.
(E) Thy1.1+CD44lo SMARTA cells (13 103) were transferred into B6 hosts (Thy1.2+), and mice were infected with LCMV or Lm-gp61 1 day later. Decreasing con-
centrations of gp66–77:I-Ab class II tetramer was used to stain SMARTA and endogenous responders at day 8 p.i. The graph displays the number of tetramer-
positive endogenous cells detected at each concentration, normalized to staining with the control tetramer hCLIP/I-Ab.
(F and G) The graph displays the percentage of tetramer-positive cells as compared to the number of tetramer-positive cells at the highest tetramer concentration
after LCMV or Lm-gp61 infection. Error bars represent the SEM (n = 4 per group).response to decreasing concentrations of their cognate peptide,
GP61–80. The maximal I-A
b-GP61–80-restricted response was de-
tected with 105 M peptide. With decreasing peptide concentra-
tions, the number of endogenous CD4+ T cell responders after
LCMV infection began to decrease immediately, showing
a half-maximal response between 1 3 107 M and 3 3 107 M
peptide. In contrast, virtually all endogenous responders gener-
ated after Lm-gp61 infection were able to respond at peptideconcentrations as low as 3 3 107 M, and they displayed
a half-maximal response at one-fifth to one-tenth the concentra-
tion of peptide (Figures 5A and 5B). Whereas LCMV induced ef-
fectors that required high concentrations of peptide for their
functional activity (1 3 107 M to 1 3 105 M), this population
was absent in the Lm-gp61-infected animals (Figure 5B). These
results indicated that LCMV infection was able to recruit both in-
termediate- and high-functional-avidity responders, whereasImmunity 28, 533–545, April 2008 ª2008 Elsevier Inc. 539
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high-avidity cells, supporting the idea that higher amounts of
antigen are available during LCMV infection.
We then asked where SMARTA responders fell in the func-
tional-avidity spectrum. SMARTA effector cells generated after
LCMV infection demonstrated a similar range of functional avid-
ities as compared to the endogenous responders in the same
host (Figure 5C). SMARTA effector cells generated after Lm-
gp61 infection, in contrast, displayed decreased functional avid-
ity as compared to the endogenous Lm-gp61 responders to the
same epitope in the same host (half-maximal responses induced
by peptide concentrations of 2 x107 M for SMARTA
responders and 5 3 108 M for endogenous CD4 responders)
(Figure 5D).
Failed SMARTA Differentiation Corresponds
to Low TCR Avidity
Because it is possible that differences in functional avidity may
not reflect differences in actual TCR avidity, we also assessed
the ability of SMARTA and endogenous responders to bind class
II tetramers for this epitope (gp66–77:I-A
b). We found that tetramer
staining of both LCMV and Lm-gp61 endogenous CD4+ T cell re-
sponders was similar in frequency to the number of responders
detected via intracellular cytokine staining (Figure S4). We then
tested the ability of both SMARTA and endogenous responders
to bind decreasing concentrations of tetramer in an equilibrium
binding assay. All stainingwas normalized to the negative control
tetramer, hCLIP:I-Ab. As with the functional-avidity assays, we
found that after LCMV infection, the number of tetramer-binding
cells began to decrease as soon as the tetramer was diluted be-
low 8 mg/ml. In contrast, the number of Lm-gp61 responders
binding tetramer remained stable at one-fourth the concentra-
tion and then began to decline as tetramer was diluted further
(Figure 5E). We compared the ability of SMARTA and endoge-
nous responders to bind tetramer by calculating the number of
tetramer-positive cells at each concentration as a percentage
of tetramer-positive cells at the highest concentration. These re-
sults again corresponded to those obtained with the functional-
avidity assay. The ability of SMARTA cells to bind tetramer in
LCMV-infected hosts mirrored that of the endogenous re-
sponders (Figure 5F), whereas the ability of SMARTA cells to
bind tetramer in Lm-gp61-infected hosts was lower than that
of the endogenous responders (Figure 5G). We plotted our re-
sults with Scatchard analysis and calculated apparent KD as pre-
viously described (Savage et al., 1999). This revealed that
whereas the apparent KD of SMARTA cells after LCMV infections
was similar to endogenous responders in the same host (17.1 nM
versus 16.6 nM), the KD of endogenous responders to Lm-gp61
was significantly lower (3.2 nM) than either SMARTA responders
in the same host (18.3 nM, p = 0.01) or endogenous responders
to LCMV (16.6 nM, p = 0.02) (Figure S5). Our results indicate that
the inability of SMARTA cells to form memory corresponds to
a decreased ability to compete for TCR signals. These findings
support the idea that decreased availability of antigen during
Lm-gp61 infection is sufficient to drive expansion and partial
effector differentiation of SMARTA cells but is not sufficient for
their differentiation into memory.
One possible explanation for these results is that responders
to each pathogen are recognizing slightly different determinants540 Immunity 28, 533–545, April 2008 ª2008 Elsevier Inc.of the gp61–80 epitope. Because the tetramer only incorporates
the gp66–77 12-mer, we find this explanation unlikely. The fre-
quency of tetramer-binding cells in each infection corresponded
to the number of IFNg-producing cells after gp61–80 peptide re-
stimulation. Furthermore, the avidity, asmeasured with the tetra-
mer, corresponded to the functional avidity, as measured with
the 20-mer gp61–80 (Figure 5). These results indicate that the rep-
ertoire of responding cells in each type of infection is probably
responding to the same epitope. As a preliminary analysis or
TCR repertoires, we analyzed Vb usage by tetramer-positive
cells (Figure S6). We found two staining patterns: subsets that
stained an equal number of LCMV and LM-gp61 responders
(Vb2,3,5,6,13) and subsets that stained more LCMV responders
than Lm-gp61 responders (Vb4,7,8.1/8.2,8.3,14). We did not ob-
serve any unique Vb-subset usage by Lm-gp61 responders.
These findings are consistent with the idea the Lm-gp61-
responding repertoire is a subset of the LCMV-responding
repertoire.
Functional-Avidity Maturation of Long-Lived
CD4+ T Cell Memory
By analyzing the functional avidities of the endogenous CD4+ T
cell memory populations after either LCMVor Lm-gp61 infection,
we further explored the role of signal strength during primary in-
fection in promoting memory differentiation and longevity. We
noted that endogenous responders with higher functional avidity
were more likely to transition from effector cells to memory cells
(Figures 6A and 6B). Even a monoclonal population of SMARTA
cells displayed a skewing toward higher functional avidity in the
transition to memory after LCMV infection (Figure 6C), agreeing
with studies indicating that responding T cells can distribute
over a range of functional avidities regardless of TCR affinity
(Kroger and Alexander-Miller, 2007; Slifka and Whitton, 2001).
Furthermore, endogenous memory cells generated by either
LCMV or Lm-gp61 infection displayed a continuous skewing
over time toward higher functional avidity (Figures 6D and 6E).
Although the overall population of memory cells decreases in
number over time, those memory cells with higher functional
avidity survive preferentially. To illustrate this, if only the numbers
of responders with high functional avidity (i.e., those that
respond to peptide concentrations % 1 3 108 M) are plotted
over time, they display virtually no decay during the memory
maintenance phase (Figure S7). These findings suggest that
the strength of the stimulatory signal delivered to CD4+ T cells
during the primary response can dictate not only recruitment
into the response, but also memory differentiation and the
subsequent longevity of memory cell populations.
DISCUSSION
Our data, plus those of others, show that SMARTA cells are an
ideal model to follow the in vivo response to LCMV infection
through the expansion, contraction, and memory phases (Whit-
mire et al., 2006). However, after infection with recombinant Lis-
teria expressing the LCMV epitope, we found that even though
the SMARTA expansion phase was intact, the effector popula-
tion rapidly contracted to zero and left no memory cells. In
mice in which the frequency of SMARTA cells approached the
endogenous precursor frequency for the gp61–80 epitope,
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(A) B6 mice were infected with LCMV. At 8 or 30 days p.i., splenocytes were restimulated over a range of GP61–80 peptide concentrations ex vivo and stained for
expression of IFNg and TNFa. The graph displays the percent maximal endogenous CD4+ T cell response induced by ex vivo peptide restimulation, as measured
by the frequency of cytokine-producing responders at each peptide concentration divided by the frequency of cytokine-producing responders at the highest
peptide concentration (1 3 105 M).
(B) Similar experiments were performed after Lm-gp61 infection.
(C) Similar experiments were performed as in (A), except that 1 3 104 CD44lo SMARTA cells were transferred 1 day prior to LCMV infection and the functional
avidity of Thy1.1+ SMARTA cells was assessed.
(D and E) Experiments similar to those in (A) and (B) were performed, except that functional avidity was assessed at days 60 and 180 p.i.
All error bars represent the SEM (n = 3–4 per group).SMARTA cells expanded 12,000- to 20,000-fold, representing at
least 12–14 cell divisions, but by day 15 p.i. 100%of the cells had
died. Meanwhile, in the same mice, there was an apparently
normal expansion, contraction, andmemory response by the en-
dogenous CD4+ T cell population. Even by day 5 p.i., before
demonstrating defects in cytokine production, SMARTA cells
had entered an irreversible pathway of programmed cell death
that could not be reversed by LCMV challenge. These results
indicate that sufficient signaling for clonal expansion and at least
partial differentiation of effector function can occur without
receiving the signals required for memory differentiation.
In vitro studies have led to a model of progressive differentia-
tion in which T cell fitness and survival are dependent on the
strength of the antigenic stimulus (Gett et al., 2003; Lanzavec-
chia and Sallusto, 2002). More recent in vivo studies of the
CD8+ T cell response have instead suggested a model of pro-
grammed differentiation, in which a short encounter with antigen
promotes the antigen-independent expansion and differentia-
tion of responding T cells (Prlic et al., 2007; Kaech and Wherry,
2007). CD4+ T cells, however, appear to require amore extended
period of antigen stimulation for the induction of a robust re-
sponse (Obst et al., 2005;Williams andBevan, 2004). This is sup-
ported by the observation that CD4+ T cell responders undergo
functional-avidity maturation throughout the primary response
(Whitmire et al., 2006). Also, the progressive skewing toward
a high-avidity repertoire throughout both primary and secondaryCD4+ T cell responses suggests an extended period of antigen-
driven repertoire selection (Savage et al., 1999). Our results sup-
port amodel in which increasing degrees of antigenic stimulation
promote hierarchical stages of differentiation. Increasing stimu-
lation would first promote clonal expansion and subsequently ef-
fector differentiation, differentiation of short-lived memory cells,
and finally differentiation of long-lived memory cells. The inability
of SMARTA cells to differentiate into memory after Lm-gp61 in-
fection, despite their massive clonal expansion and initial devel-
opment of effector function, correlates with a lower range of
functional and TCR avidity of SMARTA cells compared to the en-
dogenous CD4+ T cell responders to the same epitope. Because
the avidity of responding T cell populations has been shown to
inversely correlate with antigen dose (Rees et al., 1999), we sug-
gest that the inability of SMARTA cells to receive proper signals
for memory differentiation after Lm-gp61 challenge may be due
to limited antigen availability. The observation that memory
SMARTA rechallenged with Lm-gp61 differentiate normally and
form secondary memory fits with the notion that memory cells
have a lower activation threshold and can be more efficiently
recruited by lower amounts of antigen.
Several explanations for decreased antigen availability may be
proposed, including decreased antigen display on APCs, clonal
competition, and competition with other immunodominant epi-
topes. Of these, we have ruled out clonal competition as amecha-
nism for regulating the degree of antigen stimulation in thisImmunity 28, 533–545, April 2008 ª2008 Elsevier Inc. 541
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otherscenariosclonal competition inhibitedbothCD4+Tcellmem-
ory differentiation and maintenance (Blair and Lefrancois, 2007;
Hataye et al., 2006). The inability of SMARTA cells to differentiate
into memory after Lm-gp61 infection does not necessarily repre-
sent an abnormal differentiation event. Rather, during Lm-gp61 in-
fection, SMARTAcells represent clones that normally expand after
activation but do not receive sufficient TCR signals for memory
differentiation. SMARTA cells may thus provide a snapshot of
one differentiation stage during Lm-gp61 infection and highlight
the heterogeneous nature of the effector CD4+ T cell population.
We definitively show that the disappearance of SMARTA cells
after Lm-gp61 infection is not due to a rejection artifact peculiar
to Lm-gp61 infection but represents a genuine differentiation de-
fect. In all, these results provide a comprehensive picture of
CD4+ T cell differentiation during an immune response in which
the signaling threshold for clonal expansion is met prior to those
for effector differentiation and development of short-lived and
long-lived memory populations. Antigen-driven signals do not
represent the whole story, however, for even among the CD4+
T cell responders of the highest functional avidity substantial
contraction is observed, indicating that other signals are re-
quired for the differentiation of CD4+ memory T cells. Also, it is
unclear to what extent these findings are influenced by the dis-
tinct inflammatory environments of each infection model. Differ-
ences in the inflammatory milieu may have substantial effects on
T cell differentiation. Recent studies have found that signaling by
inflammatory mediators such as IL-12 or type I IFNs can prefer-
entially promote end-stage effector differentiation of CD8+ T
cells (Pearce and Shen, 2007; Joshi et al., 2007). We observe
normal differentiation of endogenous responders and of memory
SMARTA rechallenged with Lm-gp61, arguing against the possi-
bility that the inflammatory environment is the determining factor
for memory differentiation in our system. Furthermore, we
observe defective effector differentiation at the peak of the re-
sponse, indicating that the defect in SMARTA cells goes beyond
a switch from a memory differentiation pathway to an effector
differentiation pathway. Future studies are needed to assess
the impact of modulating antigen presentation while keeping
the bystander inflammatory environment constant.
Notably, Bim expression was increased in SMARTA effector
cells after Lm-gp61 infection. Bim is required during the contrac-
tion phase of the immune response (Pellegrini et al., 2003; Woj-
ciechowski et al., 2006) and influences other aspects of naive
and memory T cell homeostasis (Wojciechowski et al., 2007;
Hughes et al., 2008; Hutcheson et al., 2008; Weant et al.,
2008). One intriguing possibility is that the extent of antigen stim-
ulation may influence Bim expression in CD4+ T cells. However,
Bim is not differentially expressed in SMARTA cells until day 7 p.i.
(data not shown). Although Bim upregulation may explain the
disappearance of SMARTA cells after Lm-gp61 infection, it
does not explain the loss of cytokine-producing capability nor
the inability of SMARTA cells to respond to further antigenic sig-
nals at earlier time points. It remains possible that Bim is a crucial
mediator of T cell death caused by insufficient TCR-mediated
differentiation signals, but it is also possible that Bim is only
one byproduct of a differentiation program gone awry.
It has recently been shown that in some mouse models CD4+
memory T cell populations do not share the stability of CD8+542 Immunity 28, 533–545, April 2008 ª2008 Elsevier Inc.memory T cell populations, declining slowly over time (Homann
et al., 2001). In our studies of CD4+ T cell memory, we have
also observed a steady, if slow, decline in CD4+ T cell memory
populations, both by endogenous and SMARTA memory cells.
However, the rate of decline slowed over time, and we were un-
able to detect a decline in endogenous memory cells beyond
6 months p.i. Also, surviving memory cell populations consis-
tently skewed to an ever-higher functional avidity. This may rep-
resent the outgrowth of clones with high functional avidity or the
functional maturation of thememory population as a whole. Sec-
ondary challenge of mice has been shown to select for respond-
ing clones with high avidity (Rees et al., 1999), suggesting that
the skewing we observe is probably attributable to the preferen-
tial survival of memory cells with high functional avidity. These
data suggest that not only does TCR signal strength during the
primary response impact the generation of CD4+ T cell memory,
but it also influences the longevity CD4+ T cell memory popula-
tions. We propose that long-lived CD4+ memory T cells repre-
sent those responders that received the strongest stimulus
during the primary response. This also differs from implications
for CD8+memory T cells, for which it is suggested that excessive
stimulation, from either antigen or inflammatory mediators,
drives the differentiation of end-stage effector CTL that have
lost the capacity for memory differentiation (Joshi et al., 2007).
In these settings, it is likely that increasing degrees of stimulation
decrease CD8+memory T cell differentiation potential, the oppo-
site of the scenario we envisage for CD4+ T cells.
In summary, our data indicate that the signals that inducemas-
sive clonal expansion of CD4+ T cells after primary activation are
distinct from those that induce memory differentiation. We pro-
pose that increasing thestrengthof antigenicsignalspromoteshi-
erarchical differentiation of CD4+ T cell responders, with themost
profound activation signals leading to the formation of stable
CD4+memoryTcell populations. Further studies shouldelucidate
the precise role of antigen-driven stimulation inmemory develop-
ment, as well as the functional consequences of an emerging,
narrower repertoire of high-avidity CD4+ memory T cells.
EXPERIMENTAL PROCEDURES
Mice and Infections
Six- to eight-week-old C57BL/6 mice were purchased from Jackson Labora-
tories (Bar Harbor, ME). SMARTA TCR transgenic mice (Oxenius et al., 1998)
were maintained in SPF facilities at the University of Washington and the Uni-
versity of Utah. All animal experiments were conducted with the approval of
the corresponding animal use committees (IACUC) at each institution. LCMV
Armstrong 53b was grown in BHK cells and titered in Vero cells as described
(Ahmed et al., 1984). Mice were infected intraperitoneally (i.p.) with 23 105 pla-
que-forming units (PFU). Lm-gp61 expressing the gp61–80 epitope of LCMV (a
gift from M. Kaja-Krishna, University of Washington, Seattle, WA) (Way et al.,
2007) was constructed via described methods (Shen et al., 1995) and propa-
gated in BHI broth and on agar plates. Prior to infection, the bacteria were
grown to log phase and concentration determined by measuring the O.D. at
600 nm (O.D. of 1 = 1 3 109 CFU/ml). Mice were injected intravenously (i.v.)
with 2 3 105 colony-forming units (CFU). All mouse experiments were per-
formed in accordance with protocols approved by the IACUC at the University
of Washington and the University of Utah.
Adoptive Transfers
Splenocyte cell suspensions were generated from SMARTA mice. Untouched
CD4+ T cells were isolated by incubation with a biotinylated antibody cocktail
followed by antibiotin magnetic beads and depletion on a magnetic column,
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lated CD44 antibody (eBiosciences, San Diego, CA) to deplete CD44hi ‘‘mem-
ory phenotype’’ SMARTA. TCR transgenic T cell purity was assessed by stain-
ing with CD44, Va2, and Vb8.3 antibodies, followed by flow-cytometric
analysis. SMARTA cells were resuspended in PBS and injected i.v. into recip-
ient mice 1 day prior to infection. In some experiments, SMARTA cells were
incubated with 5 mM 5-(and-6)-carboxyfluorescein diacetate, succinimidyl
ester (CFSE) (Invitrogen) for 10 min in warm RPMI.
Microarray and RT-PCR
RNAwas isolated with Trizol (Invitrogen) from FACS-sorted SMARTA cells (day
8 p.i.). Message was amplified and converted to biotinylated, fragmented
cRNA with a commercially available kit per manufacturer’s instructions (Am-
bion, Austin, TX). Two biological duplicates from each group were hybridized
to Affymetrix Mouse 430 2.0 arrays. Results were normalized (GC-RMA, Bio-
conducter) and analyzed for differences in log2 expression values. Target
genes were identified for further study on the basis of > 2.5-fold increased
expression in two separate experiments, with a minimum mean of R 3-fold
increased expression. For RT-PCR, first-strand cDNA synthesis and SYBR-
green based analysis of real-time PCR amplification was performed with
a commercially available kit (Invitrogen) and a Lightcycler 480 (Roche). The
following exon-spanning primer pairs were used (50/30 ): Bim: forward-
CGGATCGGAGACGAGTTCA, reverse-TTCAGCCTCGCGGTAATCA-; Nor-1:
forward-GATCACAGAGCGACATGGGTTA, reverse-GAGCCTGTCCCTTCC
TCTGG; Bcl-2: forward-GTGGTGGAGGAACTCTTCAGGGATG, reverse-GG
TCTTCAGAGACAGCCAGGAGAAATC; TCF-1: forward-AGTCCCACAGTGT
CCTCCAG, reverse-CACGGTTACTGGGAAGAGGA; and b-catenin: forward-
CCCTGAGACGCTAGATGAGG; reverse-CATGATGGCATGTCTGGAAG. Ex-
pression was normalized to GAPDH or HPRT and displayed as a relative
n-fold increase.
Ex Vivo Restimulation and Intracellular Cytokine Staining
Splenocyte cell suspensions in RPMI supplemented with 10% fetal bovine se-
rum were plated in round-bottom 96-well plates (2–3 3 106 cells/well) and re-
stimulated for 4 hr with 1 mM (or titrated dilutions as indicated in the pertinent
figures) GP61–80 peptide from LCMV (GLKGPDIYKGVYQFKSVEFD) in the
presence of Brefeldin A (GolgiPlug, 1 ml/ml), per manufacturer’s instructions
(BD Biosciences, San Diego, CA). After restimulation, cells were stained with
fluorescently labeled cell-surface antibodies to CD4 and Thy1.1, permeabi-
lized, and stained with fluorescently labeled antibodies to IFNg, TNFa, and
IL-2, with a kit per manufacturer’s instructions (BD Biosciences, San Diego,
CA). Samples were then analyzed by flow cytometry.
Tetramer Staining and Analysis
The gp66–77:I-A
b tetramer was provided by the NIH Tetramer Core Facility
(Emory Vaccine Center, Atlanta, GA). Staining was performed at 37C for 3 hr
in RPMI containing 2% FCS, followed by washing and cell-surface staining for
CD4, CD44 and Thy1.1. Tetramer fluorescence was normalized to samples
stained with control tetramer, hCLIP:I-Ab. Scatchard plots and apparent KD
were calculated as described (Savage et al., 1999). Fluorescence units (bound)
were plotted on the x axis, and fluorescence units divided by tetramer concen-
tration (bound/free) were plotted on the y axis. KD was determined as the
inverse of the slope.
Antibodies and Flow Cytometry
Cell-surface stains were done in PBS containing 1% FBS. Intracellular stains
for cytokines and Bcl-2 were done with a kit per manufacturer’s instructions
(BDBiosciences). Antibodies conjugated to fluorescent labels were purchased
from eBiosciences (San Diego, CA) and include CD4, Thy1.1, IFNg, IL-2, TNFa,
CD62L, and CD44. Antibodies purchased from BD Biosciences (Mountain
View, CA) include Bcl-2-PE, Va2-PE, Vb8.3-FITC, and the Vb panel-staining
kit. Flow cytometry was performed with either a FACSCalibur or a FACSCanto,
and high-speed cell sorting was performed with either a FACSVantage or
a FACSAria (BD Biosciences).
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